India, May 26 -- Sernova Biotherapeutics (SVA.TO, SEOVF) announced that its Chair Ross Haghighat resigned. He tendered his resignation on May 24th and it was accepted by the Sernova Board.
Sernova Biotherapeutics is a clinical-stage company developing regenerative medicine therapeutics combining its Cell Pouch with human donor cells or stem-cell derived islet like clusters in collaboration with Evotec to create Bio-hybrid Organs to treat T1D.
For comments and feedback contact: editorial@rttnews.com
Published by HT Digital Content Services with permission from RTT News....